CD40LG and diffuse large B-cell lymphoma: All the patients enrolled in our study satisfied the WHO criteria, although some mutation-negative patients were borderline between WM and other B-lymphoproliferative disorders or between IgM multiple myeloma and diffuse large B cell lymphoma.